…
China Everbright Limited provides financial services in Hong Kong, Mainland China, and internationally. It operates through, Fund Management Business and Principal Investments Business segments. The company invests in unlisted equity securities or equity derivatives, as well as in the areas of new economy, artificial intelligence and advanced manufacturing, new energy, medical care and senior healthcare, overseas acquisition and infrastructure, real estate, aircraft industry chain, consumer market, wealth management, and others. It focuses on investing in aircraft leasing, artificial intelligence of things, and elderly care industry platforms; and investing in equity, debts, structured products, and other products. In addition, the company provides a range of financial services, including asset management, investment management, and investment advisory services, as well as return funds, bond funds, and equity funds; and fund of funds. Further, it offers management, treasury management, money lending, fund management, property and project investment, and consultancy services. The company was incorporated in 1972 and is headquartered in Hong Kong, Hong Kong. China Everbright Limited is a subsidiary of China Everbright Group Ltd.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
China Everbright Limited is a Hong Kong-based financial conglomerate affiliated with the state-owned China Everbright Group that provides banking, securities, asset management, insurance and investment holding services across Greater China; its ADR trades in the US OTC market. Long-term growth may be supported by expanding domestic wealth management, deeper capital markets and diversified fee-based businesses, and investors may find exposure to a diversified, state-affiliated financial platform attractive. Material risks include regulatory and policy uncertainty in China's financial sector, sensitivity to domestic economic and property cycles, and limited liquidity and transparency for an OTC ADR listing.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -1654.27M | -2177.93M | -1685.89M | -8623.74M | 3540.55M |
| Minority interest | -190.20M | 34.63M | -62.30M | 257.02M | -199.53M |
| Net income | -1921.53M | -1830.03M | -1824.57M | -7443.30M | 2572.84M |
| Selling general administrative | 2035.10M | 755.96M | 1215.32M | 3030.41M | 1507.22M |
| Selling and marketing expenses | - | - | 622.40M | - | - |
| Gross profit | 2667.30M | 5475.99M | 5741.50M | -5593.33M | 5081.61M |
| Reconciled depreciation | 45.81M | 50.35M | 55.00M | 66.60M | 67.22M |
| Ebit | - | - | -1113.18M | -8366.73M | 3341.03M |
| Ebitda | -755.61M | - | -1058.18M | -8300.13M | 3408.25M |
| Depreciation and amortization | - | 50.35M | 55.00M | 66.60M | 67.22M |
| Operating income | 627.86M | 4370.68M | 4361.39M | -8366.73M | 3341.03M |
| Other operating expenses | 2039.44M | 1105.31M | 540.70M | 3030.41M | 1541.06M |
| Interest expense | 898.66M | 1339.13M | 1643.69M | 1109.32M | 937.45M |
| Tax provision | 77.52M | -313.27M | 76.38M | -923.43M | 768.19M |
| Interest income | 362.35M | 556.04M | 659.68M | 563.72M | 527.59M |
| Net interest income | -537.85M | -783.09M | -984.01M | -545.59M | -409.85M |
| Income tax expense | 77.38M | -313.27M | 76.38M | -923.43M | 768.19M |
| Total revenue | 2667.30M | 5475.99M | 5929.56M | -5593.33M | 5081.61M |
| Total operating expenses | 2039.44M | 1105.31M | 352.65M | 3030.41M | 1541.06M |
| Cost of revenue | - | - | 188.06M | - | - |
| Total other income expense net | -2282.12M | -6548.60M | -6047.28M | -257.02M | 199.53M |
| Net income from continuing ops | -1734.61M | -1864.66M | -1762.27M | -7700.31M | 2772.37M |
| Net income applicable to common shares | - | - | - | -7443.30M | 2572.84M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 73776.27M | 74686.01M | 79587.92M | 84476.61M | 101793.56M |
| Other current assets | -0.00M | -1287.20M | -19353.68M | 665.62M | 1618.00M |
| Total liab | 45495.65M | 42035.93M | 45482.14M | 32978.67M | 35023.18M |
| Total stockholder equity | 27393.64M | 29726.66M | 30989.72M | 34489.20M | 46936.32M |
| Other current liab | -2892.94M | -12560.24M | 18370.85M | 5081.49M | 4557.78M |
| Common stock | 9617.16M | 9618.10M | 9618.10M | 9618.10M | 9618.10M |
| Capital stock | 9618.10M | 9618.10M | 9618.10M | 9618.10M | 9618.10M |
| Retained earnings | 15297.51M | 18140.05M | 19637.06M | 22751.63M | 30857.13M |
| Other liab | - | - | - | 8539.35M | 11176.07M |
| Other assets | - | 74686.01M | -7231.91M | 11894.83M | 12470.66M |
| Cash | 8533.94M | 8422.12M | 9588.08M | 7945.64M | 6894.26M |
| Total current liabilities | 11694.81M | 2574.24M | 21333.34M | 19523.83M | 20293.49M |
| Current deferred revenue | - | - | -2975.77M | - | - |
| Net debt | 25013.81M | -8422.12M | -9531.12M | 25033.03M | 28128.92M |
| Short term debt | 11694.81M | 12560.24M | 13.27M | - | - |
| Short long term debt total | 33547.75M | 30161.06M | 34630.54M | 32978.67M | 35023.18M |
| Other stockholder equity | 664.73M | 1968.52M | 1734.56M | 24871.11M | 37318.23M |
| Property plant equipment | - | - | - | 5419.89M | 5950.30M |
| Total current assets | 17773.25M | 8422.12M | 23366.98M | 8553.11M | 7573.31M |
| Long term investments | 53546.15M | 54400.86M | 57404.07M | 63506.95M | 81152.05M |
| Net tangible assets | - | - | - | 36830.29M | 49277.49M |
| Short term investments | 5435.62M | - | 8846.05M | - | - |
| Net receivables | 3803.69M | -185.60M | 3403.52M | 607.47M | 679.05M |
| Inventory | - | 1472.81M | 1529.34M | 1383.81M | 1742.45M |
| Accounts payable | 2892.94M | 2574.24M | 2962.49M | 3523.04M | 3237.96M |
| Accumulated other comprehensive income | 1814.24M | - | 1734.56M | - | - |
| Non currrent assets other | 2153.85M | -54856.85M | -63452.85M | -64028.67M | -81749.59M |
| Non current assets total | 56003.02M | 52137.64M | 63452.85M | 64028.67M | 81749.59M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 1106.46M | 1704.00M | 329.52M | -7.91M |
| Change to liabilities | - | - | - | 0.00M | -157.76M |
| Total cashflows from investing activities | -721.09M | 1106.46M | 1704.00M | 329.52M | 482.41M |
| Net borrowings | 628.81M | -1880.23M | -517.52M | -649.58M | 2816.79M |
| Total cash from financing activities | 429.56M | -3612.08M | -3112.70M | -2782.39M | 924.19M |
| Change to operating activities | - | - | - | - | -1053.78M |
| Net income | -2004.30M | -2177.93M | -1685.89M | -8623.74M | 3540.55M |
| Change in cash | 95.78M | -1141.10M | 1585.48M | 1051.38M | -1965.88M |
| Begin period cash flow | 8438.16M | 9531.12M | 7945.64M | 6894.26M | 8860.14M |
| End period cash flow | 8533.94M | 8390.02M | 9531.12M | 7945.64M | 6894.26M |
| Total cash from operating activities | 243.09M | 1691.43M | 3176.93M | 4059.56M | -3505.43M |
| Issuance of capital stock | - | - | - | - | 361.67M |
| Depreciation | 45.81M | 50.35M | 55.00M | 66.60M | 67.22M |
| Other cashflows from investing activities | 1.19M | 975.74M | 1708.33M | 263.00M | 967.46M |
| Dividends paid | 168.24M | 331.72M | 594.50M | -847.73M | -1240.23M |
| Change to inventory | - | 26.92M | 34.18M | - | -8.77M |
| Change to account receivables | - | 220.48M | -308.12M | - | 309.71M |
| Sale purchase of stock | - | - | -2325.54M | - | -130.56M |
| Other cashflows from financing activities | -62.65M | -1400.12M | -2000.69M | 20353.13M | 51954.08M |
| Change to netincome | - | - | - | 11413.58M | 419.11M |
| Capital expenditures | 1.60M | 14.76M | 4.62M | 4.91M | 3.95M |
| Change in working capital | 484.39M | 2669.17M | 4243.86M | 10729.70M | -6653.19M |
| Other non cash items | 2247.39M | 1149.85M | 563.96M | 1887.01M | -460.01M |
| Free cash flow | 241.48M | 1676.67M | 3172.31M | 4054.65M | -3509.37M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CEVIY China Everbright Ltd ADR |
- -% |
5.40 | - | 121.95 | 0.94 | 0.18 | 8.92 | 0.74 |
| BLK BlackRock Inc |
-32.52 2.78% |
1136.69 | 26.25 | 19.57 | 6.33 | 2.90 | 6.35 | 17.13 |
| BX Blackstone Group Inc |
- -% |
115.99 | 33.20 | 20.12 | 11.05 | 11.56 | 9.14 | 15.74 |
| IVSBF Investor AB ser. B |
- -% |
41.39 | 4.67 | 3.83 | 3.78 | 1.13 | 4.15 | 1.68 |
| KKR KKR & Co. Inc. |
-1.58 1.69% |
92.10 | 32.68 | 13.66 | 3.58 | 3.22 | 0.68 | 1.47 |
China Everbright Limited provides financial services in Hong Kong, Mainland China, and internationally. It operates through, Fund Management Business and Principal Investments Business segments. The company invests in unlisted equity securities or equity derivatives, as well as in the areas of new economy, artificial intelligence and advanced manufacturing, new energy, medical care and senior healthcare, overseas acquisition and infrastructure, real estate, aircraft industry chain, consumer market, wealth management, and others. It focuses on investing in aircraft leasing, artificial intelligence of things, and elderly care industry platforms; and investing in equity, debts, structured products, and other products. In addition, the company provides a range of financial services, including asset management, investment management, and investment advisory services, as well as return funds, bond funds, and equity funds; and fund of funds. Further, it offers management, treasury management, money lending, fund management, property and project investment, and consultancy services. The company was incorporated in 1972 and is headquartered in Hong Kong, Hong Kong. China Everbright Limited is a subsidiary of China Everbright Group Ltd.
| Name | Title | Year Born |
|---|---|---|
| Mr. Mingao Zhang | Pres & Exec. Director | 1967 |
| Mr. Hongyang Wang | VP & Exec. Director | 1977 |
| Mr. Yanwu Yin | VP & Exec. Director | 1974 |
| Mr. Zhao Zehui | Sr. Investment Director | NA |
| Mr. Ming Kin Chan | Gen. Counsel | 1969 |
| Ms. Kim Ying Wan | Company Sec. and Director of Company Secretarial of Legal, Compliance & Company Secretarial | NA |
| Ms. Shengyan Fan | MD of M&A Department & Managing Partner of CEL Catalyst China Israel Fund | NA |
| Mr. John Chan | MD of M&A Department & Managing Partner of CEL Catalyst China Israel Fund | NA |
| Ms. Jane Zhang | Managing Director of Fund of Funds Investment Team | NA |
| Mr. Yizhe Wang | Managing Director of Super Acquisition Fund Department II | 1980 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.